Nevertheless, it is essential to emphasize that our study represents a preliminary snapshot based on available data and methodologies
While retatrutide shares some common side effects with GLP-1 receptor agonists, such as gastrointestinal events, the frequency and severity of these adverse events appear to be dose-dependent and can be reduced by the use of a lower starting doses of retatrutide
Furthermore, these nanocarriers are capable of depleting GSH levels in the tumor microenvironment to augment stress on cells and induce cell death pathways, including ferroptosis, making cancer cells sensitive to treatment Fig
Lahiri DK, Chen D, Ge YW, Bondy SC, Sharman EH
Whether taken by pill or injection, GLP-1 drugs can be a life-changing treatment for people with type 2 diabetes and/or obesity
Next, we identified those patients with at least one 24-hour urine collection before initiation of GLP and at least one 24-hour urine collection while still on GLP